HHealth Read More Scientists create light-controlled versions of cholesterolDecember 16, 2025 High levels of cholesterol are linked to heart disease, stroke, and many other health problems. However, this complex…
HHealth Read More Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancerDecember 5, 2025 Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows…
HHealth Read More New signaling molecule drives development of tissue resident memory T cellsNovember 23, 2025 We owe a lot to tissue resident memory T cells (TRM). These specialized immune cells are among the…
HHealth Read More Intranasal nanomedicine shows promise against glioblastomaNovember 22, 2025 Researchers at Washington University School of Medicine in St. Louis, along with collaborators at Northwestern University, have developed…
HHealthcare Read More 2 No-Brainer Healthcare Stocks to Buy NowNovember 19, 2025 Pfizer’s acquisition of obesity drugmaker Metsera positions the pharmaceutical giant to compete in a market expected to reach…
HHealth Read More The caffeine conundrum in rapid depression treatmentsNovember 11, 2025 Perhaps the most intriguing implication of recent breakthrough research lies in an unexpected connection: the most rigorous mechanistic…
HHealth Read More New NIH grants fuel research in oral cancer treatment and pain reliefNovember 8, 2025 Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University…
SScience Read More Comprehensive kinase atlas reveals new insights into cell signaling and diseaseNovember 7, 2025 The enzyme RNA polymerase II transcribes genes into messenger RNA. This process is guided by modifications to the enzyme’s…
HHealth Read More Scripps Research professor wins $3.2 million grant to unravel the mysteries of type 1 diabetesOctober 29, 2025 Luc Teyton, professor in the Department of Immunology and Microbiology at Scripps Research, has received a five-year, $3.2…
HHealth Read More Experimental compound reduces cell death, inflammation, and organ damage in diabetesOctober 29, 2025 An experimental compound reduced the cell death, inflammation, and organ damage seen with diabetes. Led by NYU Langone…
HHealth Read More CRISPR therapy shows promise against influenza in human lung chipsOctober 16, 2025 The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to…
GGenetics Read More Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines ConferenceOctober 14, 2025 Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference London – 14 October 2025 – Purespring…